| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 6.0 | 6.9 |
| Gross profit | 3.3 | 2.7 |
| Profit before tax | -1.5 | -2.4 |
| Net income | -1.5 | -0.9 |
| EPS (diluted, $ a share) | $-0.09 | $-0.06 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -12.9% |
|---|---|
| Gross margin | 54.8% |
| Operating margin | -27.0% |
10-Q filed with the SEC, NASDAQ: SRTS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Sensus Healthcare, Inc.: key numbers
- Share price
- $2.34Close, Nov 16
- Market cap
- $38.5M
- Shares outstanding
- 16.46MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Sensus Healthcare, Inc.
All →Sensus Healthcare Financial Results
Sensus Healthcare reported Q3 2026 revenue of $6.0 million, a 13% decrease year-over-year due to a shift in product mix and the absence of sales to a historically large customer. Despite lower revenue, gross margin improved significantly to 55% from 39.1% in the prior year, and the company reached a milestone of 1,000 SRT systems placed.
- Term
- Q3 2026
“Our third quarter results reflect continued progress in building a broader, more diversified customer base and advancing our business toward sustainable profitability.”
Joseph Sardano, Chairman and Chief Executive Officer
“Our focus is on converting these opportunities into sales, increasing utilization and building a more diversified, sustainably profitable business.”
Joseph Sardano, Chairman and Chief Executive Officer